2 results
Approved WMOCompleted
Primary Objective•*To evaluate the relative oral bioavailability of SMV, ODV, and AL-335 when administered as different concept fixed-dose combination (FDC) formulations compared to the single agents when administered together, all under fed…
Approved WMORecruiting
To study the safety and efficacy of mitapivat in the treatment of adult subjects with sickle cell disease.